Immunotherapy With CD19 CAR γδT-cells for B-Cell Lymphoma, ALL and CLL
Clinical trial NCT02656147 · UNKNOWN
Trial details
- NCT number
- NCT02656147
- Sponsor
- Beijing Doing Biomedical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-01
- Primary completion
- 2019-04-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.